Founded in 2000, biomedion develops the neuronOS platform, a modern software GxP data cloud platform in the life and health sciences industry to preserve GLP raw data from instruments and GxP information to ensure compliance with regulatory provisions. Headquartered in Berlin with additional offices in Munich (Germany) and Phoenix (United States), biomedion serves worldwide leading top 20 pharmaceutical and biosimilar companies as well as supporting Contract Research Organisations (CROs) and emerging biotechs in Europe and North America.